HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
Cohen
Myron S
MS
D000293:Adolescent; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D061466:Lopinavir; D008253:Macaca mulatta; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use; D012742:Sex Offenses; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004338:Drug Combinations; D011744:Pyrimidinones; C109078:lamivudine, zidovudine drug combination; D061466:Lopinavir; D019259:Lamivudine; D015215:Zidovudine